Grifols, S.A Revenue 2012-2020 | GRFS

Grifols, S.A annual/quarterly revenue history and growth rate from 2012 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Grifols, S.A revenue for the quarter ending June 30, 2020 was $M, a 100% decline year-over-year.
  • Grifols, S.A revenue for the twelve months ending June 30, 2020 was $2.732B, a 41.59% decline year-over-year.
  • Grifols, S.A annual revenue for 2019 was $5.711B, a 7.77% increase from 2018.
  • Grifols, S.A annual revenue for 2018 was $5.299B, a 8.57% increase from 2017.
  • Grifols, S.A annual revenue for 2017 was $4.881B, a 8.91% increase from 2016.
Grifols, S.A Annual Revenue
(Millions of US $)
2019 $5,711
2018 $5,299
2017 $4,881
2016 $4,482
2015 $4,369
2014 $4,460
2013 $3,642
2012 $3,371
2011 $2,501
Grifols, S.A Quarterly Revenue
(Millions of US $)
2020-06-30
2020-03-31
2019-06-30 $1,424
2018-06-30 $1,308
2017-06-30 $1,244
2017-03-31 $1,131
2016-12-31 $1,186
2016-09-30 $1,116
2016-06-30 $1,121
2016-03-31 $1,058
2015-12-31 $1,166
2015-09-30 $1,081
2015-06-30 $1,097
2015-03-31 $1,023
2014-12-31 $1,041
2014-09-30 $1,098
2014-06-30 $1,086
2014-03-31 $1,111
2013-12-31 $923
2013-09-30 $882
2013-06-30 $925
2013-03-31 $903
2012-12-31 $851
2012-09-30 $804
2012-06-30 $835
2012-03-31 $863
2011-12-31 $796
2011-09-30 $807
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $11.468B $5.711B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.246B 43.37
Takeda Pharmaceutical (TAK) Japan $59.398B 10.35
Astellas Pharma (ALPMY) Japan $28.616B 14.50
Eisai (ESALY) Japan $26.798B 22.65
UCB SA (UCBJF) Belgium $22.446B 0.00
Merck (MKGAF) Germany $18.876B 24.75
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $13.825B 45.04
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $9.500B 36.78
IPSEN SA ADR (IPSEY) France $9.086B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.773B 12.86
Ionis Pharmaceuticals (IONS) United States $7.165B 45.39
Orion OYJ (ORINY) Finland $7.077B 24.56
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
United Therapeutics (UTHR) United States $4.737B 10.95
Arrowhead Pharmaceuticals (ARWR) United States $4.680B 0.00
Evotec AG (EVTCY) Germany $4.014B 139.34
FibroGen (FGEN) United States $3.963B 0.00
Hypermarcas (HYPMY) Brazil $3.730B 13.72
Nektar Therapeutics (NKTR) United States $3.639B 0.00
ChemoCentryx (CCXI) United States $3.622B 0.00
PTC Therapeutics (PTCT) United States $3.216B 0.00
Sage Therapeutics (SAGE) United States $3.124B 0.00
Pacira BioSciences (PCRX) United States $2.560B 67.29
Xencor (XNCR) United States $2.411B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.297B 11.12
Revolution Medicines (RVMD) United States $2.041B 0.00
Corcept Therapeutics (CORT) United States $1.989B 18.31
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.887B 0.00
Cronos Group (CRON) Canada $1.833B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.585B 11.01
USANA Health Sciences (USNA) United States $1.569B 14.78
Heron Therapeutics (HRTX) United States $1.475B 0.00
Zogenix (ZGNX) United States $1.351B 0.00
Trillium Therapeutics (TRIL) Canada $1.302B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.283B 12.23
Karyopharm Therapeutics (KPTI) United States $1.182B 0.00
Indivior (INVVY) United States $1.137B 14.09
Theravance Biopharma (TBPH) Cayman Islands $1.127B 0.00
Translate Bio (TBIO) United States $1.095B 0.00
Esperion Therapeutics (ESPR) United States $1.053B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.991B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.930B 579.13
Vectura Group (VEGPF) United Kingdom $0.894B 0.00
VAXART, INC (VXRT) United States $0.871B 0.00
Endo (ENDP) Ireland $0.745B 1.10
ImmunoGen (IMGN) United States $0.716B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.705B 0.00
Tilray (TLRY) Canada $0.691B 0.00
Collegium Pharmaceutical (COLL) United States $0.680B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.667B 0.00
Molecular Templates (MTEM) United States $0.639B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.594B 0.00
Flexion Therapeutics (FLXN) United States $0.590B 0.00
Radius Health (RDUS) United States $0.583B 0.00
Ocular Therapeutix (OCUL) United States $0.557B 0.00
Siga Technologies (SIGA) United States $0.555B 59.17
Aerie Pharmaceuticals (AERI) United States $0.548B 0.00
Ardelyx (ARDX) United States $0.535B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.529B 0.00
Altimmune (ALT) United States $0.461B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.439B 0.00
Harpoon Therapeutics (HARP) United States $0.434B 0.00
Organogenesis Holdings (ORGO) United States $0.432B 0.00
Akebia Therapeutics (AKBA) United States $0.423B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.408B 20.36
TherapeuticsMD (TXMD) United States $0.381B 0.00
Redhill Biopharma (RDHL) Israel $0.371B 0.00
MEI Pharma (MEIP) United States $0.366B 0.00
DURECT (DRRX) United States $0.353B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.351B 8.69
PROFOUND MEDICL (PROF) Canada $0.338B 0.00
IMV INC (IMV) Canada $0.331B 0.00
Innate Pharma SA (IPHYF) France $0.324B 0.00
Jounce Therapeutics (JNCE) United States $0.323B 15.31
Concert Pharmaceuticals (CNCE) United States $0.321B 0.00
Aquestive Therapeutics (AQST) United States $0.300B 0.00
Rafael Holdings (RFL) United States $0.281B 0.00
Xeris Pharmaceuticals (XERS) United States $0.265B 0.00
Calithera Biosciences (CALA) United States $0.259B 0.00
Lannett Co Inc (LCI) United States $0.249B 5.78
Nature's Sunshine Products (NATR) United States $0.243B 24.00
KalVista Pharmaceuticals (KALV) United States $0.240B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.239B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.221B 0.00
CASI Pharmaceuticals (CASI) United States $0.216B 0.00
Heat Biologics (HTBX) United States $0.207B 0.00
OptiNose (OPTN) United States $0.201B 0.00
Nivalis Therapeutics (ALPN) United States $0.198B 0.00
Otonomy (OTIC) United States $0.188B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.160B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.158B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.140B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.129B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.124B 0.00
Champions Oncology (CSBR) United States $0.110B 0.00
Aclaris Therapeutics (ACRS) United States $0.109B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.107B 0.00
MediWound (MDWD) Israel $0.103B 0.00
Lipocine (LPCN) United States $0.100B 0.00
CTI BioPharma (CTIC) United States $0.088B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.088B 0.00
Biomerica (BMRA) United States $0.083B 0.00
ElectroCore (ECOR) United States $0.083B 0.00
Hemispherx BioPharma (AIM) United States $0.082B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.080B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.079B 0.00
Addex Therapeutics (ADXN) Switzerland $0.074B 0.00
Novan (NOVN) United States $0.072B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.067B 0.00
Infinity Pharmaceuticals (INFI) United States $0.064B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.058B 0.00
SCYNEXIS (SCYX) United States $0.056B 0.00
Recro Pharma (REPH) United States $0.055B 0.00
IsoRay (ISR) United States $0.053B 0.00
CV Sciences (CVSI) United States $0.051B 0.00
KemPharm (KMPH) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.82
Natural Alternatives (NAII) United States $0.049B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.049B 0.00
India Globalization Capital (IGC) United States $0.049B 0.00
Onconova Therapeutics (ONTX) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
GTx (ONCT) United States $0.043B 0.00
PolarityTE (PTE) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.036B 9.20
Bellicum Pharmaceuticals (BLCM) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
AgeX Therapeutics (AGE) United States $0.034B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.033B 0.00
Neos Therapeutics (NEOS) United States $0.033B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.032B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
Sundial Growers (SNDL) Canada $0.028B 0.00
Midatech Pharma (MTP) United Kingdom $0.025B 0.00
Vical (BBI) United States $0.023B 0.00
Regulus Therapeutics (RGLS) United States $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.016B 23.73
Bio-Path Holdings (BPTH) United States $0.016B 0.00
HANCOCK JAFFE (HJLI) United States $0.015B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.014B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
JanOne (JAN) United States $0.010B 0.00
China SXT Pharmaceuticals (SXTC) China $0.009B 0.00
Shineco (TYHT) China $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00